Advertisement
Research Article| Volume 81, ISSUE 1, P140-147, January 1973

Inhibition of ADP-induced platelet aggregation by furosemide

  • Ennio C. Rossi
    Correspondence
    Reprint requests: Dr. Ennio C. Rossi, Northwestern University School of Medicine, 303 E. Chicago Ave., Chicago, Ill. 60611.
    Affiliations
    From the Department of Medicine, Northwestern University School of Medicine Chicago, Ill. U.S.A.

    From the Veterans Administration Research Hospital, Chicago, Ill. U.S.A.
    Search for articles by this author
  • Nathan W. Levin
    Affiliations
    From the Department of Medicine, Northwestern University School of Medicine Chicago, Ill. U.S.A.

    From the Veterans Administration Research Hospital, Chicago, Ill. U.S.A.
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Furosemide in vitro is an inhibitor of primary ADP-induced platelet aggregation. As such, furosemide also inhibits collagen-induced aggregation and the secondary wave of epinephrine-induced aggregation. Concentrations of furosemide which clearly inhibit collagen-induced platelet aggregation do not inhibit collagen-induced release of ADP. Thus the effect of furosemide is distinct from that of aspirin and other anti-inflammatory drugs which inhibit platelet release but do not inhibit primary ADP-induced platelet aggregation. The inhibitory effect of furosemide is competitive, demonstrable in heparinized as well as citrated platelet-rich plasma, and it is not corrected by calcium. The concentration of furosemide required for in vitro inhibition (1 to 5mM) can not be achieved in vivo. However, the study of compounds related to furosemide could lead to the discovery of a clinically useful inhibitor of primary ADP-induced platelet aggregation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Born GVR
        • Cross MJ
        The aggregation of blood platelets.
        J Physiol. 1963; 168: 178-195
        • Born GVR
        Strong inhibition by 2-chloroadenosine of the aggregation of blood platelets by adenosine diphosphate.
        Nature. 1964; 202: 95-96
        • Born GVR
        • Cross MJ
        Effects of inorganic ions and of plasma proteins on the aggregation of blood platelets by adenosine diphosphate.
        J Physiol. 1964; 170: 397-414
        • Salzman EW
        • Chambers DA
        Inhibition of ADP-induced platelet aggregation by substituted amino acids.
        Nature. 1964; 204: 698-700
        • Skoza L
        • Zucker MB
        • Jerushalmy Z
        • et al.
        Kinetic studies of platelet aggregation induced by adenosine diphosphate and its inhibition by chelating agents, guanidino compounds, and adenosine.
        Thromb Diath Haemorrh. 1967; 18: 713-725
        • Wolfe SM
        • Shulman NR
        Adenyl cyclase activity in human platelets.
        Biochem Biophys Res Commun. 1969; 35: 265-272
        • Salzman EW
        • Neri LL
        Cyclic 3′, 5′-adenosine monophosphate in human blood platelets.
        Nature. 1969; 224: 609-610
        • Marquis NR
        • Vigdahl RL
        • Tavormina PA
        Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1.
        Biochem Biophys Res Commun. 1969; 36: 965-972
        • Weiss HJ
        • Aledort LM
        • Kochwa S
        The effect of salicylates on the hemostatic properties of platelets in man.
        J Clin Invest. 1968; 47: 2169-2180
        • Packhan MA
        • Warrior ES
        • Glynn MF
        • et al.
        Alteration of the response of platelets to surface stimuli by pyrazole compounds.
        J Exp Med. 1967; 126: 171-188
        • Mills DCB
        • Roberts GCK
        Membrane active drugs and the aggregation of human blood platelets.
        Nature. 1967; 213: 35-38
        • Emmons PR
        • Harrison MJG
        • Honour AJ
        • et al.
        Effect of dipyridamole on human platelet behaviour.
        Lancet. 1965; 2: 603-606
        • Zucker MB
        • Peterson J
        Effect of acetylsalicylic acid, other nonsteroidal antiinflammatory agents, and dipyridamole on human blood platelets.
        J Lab Clin Med. 1970; 76: 66-75
        • Born GVR
        Aggregation of blood platelets by adenosine diphosphate and its reversal.
        Nature. 1962; 194: 927-929
        • Green D
        • Narayan SA
        • Louis G
        Platelet aggregation employing human collagen.
        Clin Res. 1971; 19 (Abst.): 420
        • Kinlough-Rathbone RL
        • Packham MA
        • Mustard JF
        The effect of glucose on adenosine diphosphate-induced platelet aggregation.
        J Lab Clin Med. 1970; 75: 80-87
        • Hajdú VP
        • Häussler A
        Untersuchungen mit dem salidiureticum 4-chloro-N-(2- furylmethyl)-5-sulfamyl-anthranilsäure.
        Arzneimittel Forsch. 1964; 14: 709-710
        • Brecher G
        • Cronkite EP
        Morphology and enumeration of human blood platelets.
        J Appl Physiol. 1950; 3: 365-377
        • Senft G
        On the action of benzothiadiazines and related compounds on enzymic and hormonal regulation of carbohydrate metabolism.
        in: Beyer KH Salt and Water balance. Pergamon Press, London1968: 83-91
        • Mills DCB
        • Smith JB
        • Born GVR
        Pharmacology of platelet aggregation inhibition.
        Thromb Diath Haemorrh Supplement. 1970; 42: 175-184
        • Abdulla YH
        B-adrenergic receptors in human platelets.
        J Atheroscler Res. 1969; 9: 171-177
        • Smythe HA
        • Ogryzlo MA
        • Murphy EA
        • et al.
        The effect of sulfinpyrazone (anturan) on platelet economy and blood coagulation in man.
        Can Med Assoc J. 1965; 92: 818-821
        • Born GVR
        • Honour AJ
        • Mitchell JRA
        Inhibition by adenosine and by 2-chloroadenosine of the formation and embolization of platelet thrombi.
        Nature. 1964; 202: 761-765
        • Kloeze J
        Influence of prostaglandins on platelet adhesiveness and platelet aggregation.
        in: Bergstrom S Samuelsson B Proceedings of the Second Nobel Symposium, Stockholm, June, 1966 Almqvist and Wiskell, Stockholm1962: 241
        • Carlson LA
        • Irion E
        • Oro L
        Effect of infusion of prostaglandin E1 on the aggregation of blood platelets in man.
        Life Sci. 1968; 7: 85-90
        • Harker LA
        • Slichter SJ
        Platelets and fibrinogen in patients with prosthetic heart valves.
        N Engl J Med. 1970; 283: 1302-1305
        • Mustard JF
        • Packham MA
        Factors influencing platelet function: adhesion, release, and aggregation.
        Pharmacol Rev. 1970; 22: 97-187
        • Horch U
        • Kadatz R
        • Kopitar Z
        • et al.
        Pharmacology of dipyridamole and its derivatives.
        Thromb Diath Haemorrh Supplement. 1970; 42: 253-266
        • Didisheim P
        • Owen Jr, CA
        Effect of dipyridamole (Persantin) and its derivatives on thrombosis and platelet function.
        Thromb Diath Haemorrh Supplement. 1970; 42: 267-275
        • Hassanein AA
        • Turpie AGG
        • McNicol GP
        • et al.
        The action of pyrimido-pyrimidine compounds on platelet behaviour in vitro.
        Thromb Diath Haemorrh Supplement. 1970; 42: 277-289